Immunofluorescence analysis showed that the reduced expression of AGR2 effectively down-regulated β-DG protein in the breast cancer cells (AGR2 knock-down did not change co-localization) (Figure 3(B)). This evidence concerns the gene AGR2 and breast carcinoma.